| mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0007 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.27 |
0.0007 |